Docking, molecular dynamics and free energy studies on aspartoacylase mutations involved in Canavan disease

dc.contributor.authorKocak, Abdulkadir
dc.contributor.authorYildiz, Muslum
dc.date.accessioned2025-10-29T11:26:29Z
dc.date.issued2017
dc.departmentFakülteler, Temel Bilimler Fakültesi, Kimya Bölümü
dc.description.abstractThe disruption of aspartoacylase enzyme's catalytic activity causes fatal neurodegenerative Canavan disease. By molecular dynamics and docking methods, here we studied two deleterious mutations that have been identified in the Canavan patients' genotype E285A, F295S, and revealed the possible cause for the enzyme inhibition due to the drastic changes in active site dynamics, loss of interactions among Arg 71, Arg 168 and the substrate and pKa value of critical G1u178 residue. In addition to changes in the enzyme dynamics, free energy calculations show that the binding energy of substrate decreases dramatically up on mutations. (C) 2017 Elsevier Inc. All rights reserved.
dc.identifier.doi10.1016/j.jmgm.2017.03.011
dc.identifier.endpage53
dc.identifier.issn1093-3263
dc.identifier.issn1873-4243
dc.identifier.orcid0000-0001-6891-6929
dc.identifier.pmid28349879
dc.identifier.scopus2-s2.0-85016053649
dc.identifier.scopusqualityQ2
dc.identifier.startpage44
dc.identifier.urihttps://doi.org/10.1016/j.jmgm.2017.03.011
dc.identifier.urihttps://hdl.handle.net/20.500.14854/10300
dc.identifier.volume74
dc.identifier.wosWOS:000403624700006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofJournal of Molecular Graphics & Modelling
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20251020
dc.subjectNeurodegenerative
dc.subjectCanavan
dc.subjectDocking
dc.subjectMolecular dynamics
dc.subjectASPA
dc.subjectMutation
dc.titleDocking, molecular dynamics and free energy studies on aspartoacylase mutations involved in Canavan disease
dc.typeArticle

Dosyalar